TRACEY SIZEMORE: Open Payments
NPI 1962911248 · STANTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 19 payments from 8 companies in 2025. Trend: 2023 $522 · 2024 $562 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $118 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Ardelyx, Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: FARXIGA, JARDIANCE, MOUNJARO, IBSRELA, Wegovy, TRELEGY ELLIPTA, Cologuard Collection Kit, CAPLYTA.
Industry payments across KY — which companies pay providers there.
